Evidence map›Paper›PMID 29269352›Full record

ArticleJournal of the American Heart Association2017

Association Between

Teresa K Chen, Ronit Katz, Michelle M Estrella, Orlando M Gutierrez, Holly Kramer, Wendy S Post, Michael G Shlipak, Christina L Wassel, Carmen A Peralta

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Journal of the American Society of Nephrology : JASN · 2019
    Pooled it
  2. Trial
  3. Article
  4. Kidney international reports · 2025
    Article
  5. Review
  6. Article
  7. Kidney international reports · 2021
    Article
  8. Association ofJournal of the American Heart Association · 2020
    Article
  9. Chronic stress: a crucial promoter of cell apoptosis in atherosclerosis.The Journal of international medical research · 2020
    Article
  10. Association ofCirculation · 2019
    Article
  11. Ten years in: APOL1 reaches beyond the kidney.Current opinion in nephrology and hypertension · 2019
    Review
  12. The Impact of APOL1 on Chronic Kidney Disease and Hypertension.Advances in chronic kidney disease · 2019
    Review
  13. Article
  14. Observational
  15. Circulation. Genomic and precision medicine · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

Teresa K ChenDivision of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD tchen39@jhmi.edu.
Ronit KatzDepartment of Medicine, Kidney Research Institute, University of Washington, Seattle, WA.
Michelle M EstrellaKidney Health Research Collaborative, Department of Medicine, University of California, San Francisco, CA.
Orlando M GutierrezDepartments of Medicine and Epidemiology, University of Alabama at Birmingham, AL.
Holly KramerDivision of Nephrology, Departments of Medicine and Public Health Sciences, Loyola University, Maywood, IL.
Wendy S PostDivision of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD.
Michael G ShlipakKidney Health Research Collaborative, Department of Medicine, University of California, San Francisco, CA.
Christina L WasselDepartment of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Colchester, VT.
Carmen A PeraltaKidney Health Research Collaborative, Department of Medicine, University of California, San Francisco, CA.
Johns Hopkins University · USSan Francisco VA Medical Center · USLoyola University Chicago · USUniversity of Alabama at Birmingham · USUniversity of California, San Francisco · USUniversity of Vermont · USUniversity of Washington · US

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
Institute for Clinical and Translational ResearchUL1TR001079 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2013 to 2017
$60.1M
Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Andrea L Hevener · 2003 to 2026
$40.4M
Wake Forest Clinical and Translational Science AwardUL1TR001420 · NCATS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ARD, JAMY D, FOLEY, KRISTIE L · 2015 to 2023
$32.3M
Clinical and Translational Science AwardUL1TR000040 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2012 to 2015
$26.2M
SUBCLINICAL CARDIOVASCULAR DISEASE COORDINATING CENTERN01HC95159 · NHLBI · UNIVERSITY OF WASHINGTON · PI KRONMAL, RICHARD A · 2007 to 2014
$19.6M
University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Kirk Michael Habegger · 2013 to 2026
$19.5M
SUBCLINICAL CARDIOVASCULAR DISEASE STUDY--FIELD CENTERN01HC95160 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WATSON, KAROL · 2007 to 2015
$7.7M
SUBCLINICAL CARDIOVASCULAR DISEASE STUDY-FIELD CENTERN01HC95164 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LIU, KIANG · 2007 to 2015
$7.0M
SUBCLINICAL CARDIOVASCULAR DISEASE STUDY--FIELD CENTERN01HC95161 · NHLBI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI SHEA, STEVEN · 2007 to 2014
$6.4M
SUBCLINICAL CARDIOVASCULAR DISEASE STUDY--FIELD CENTERN01HC95165 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BURKE, GREGORY L · 2007 to 2014
$6.3M
SUBCLINICAL CARDIOVASCULAR DISEASE STUDY--FIELD CENTERN01HC95163 · NHLBI · UNIVERSITY OF MINNESOTA · PI FOLSOM, AARON R · 2007 to 2014
$6.1M
NCATS NIH HHS UL1 TR000040NCATS NIH HHS UL1 TR001079NCATS NIH HHS UL1 TR001420NCATS NIH HHS UL1 TR001881NHLBI NIH HHS N01HC95159NHLBI NIH HHS N01HC95160NHLBI NIH HHS N01HC95161NHLBI NIH HHS N01HC95162NHLBI NIH HHS N01HC95163NHLBI NIH HHS N01HC95164NHLBI NIH HHS N01HC95165NHLBI NIH HHS N01HC95166NHLBI NIH HHS N01HC95167NHLBI NIH HHS N01HC95168NHLBI NIH HHS N01HC95169NIDDK NIH HHS P30 DK063491NIDDK NIH HHS P30 DK079626NIDDK NIH HHS R03 DK095877NIH HHS HHSN263201500003I
6 · The paper itself

Abstract

backgroundMETHODS AND

resultsCross-sectional associations of

conclusionsAmong blacks without baseline CVD, the

Indexed as

EthnicityMutation, MissenseAgedAged, 80 and overApolipoprotein L1AtherosclerosisCardiovascular DiseasesCross-Sectional StudiesDNADNA Mutational AnalysisFemaleGenotypeHumansIncidenceMaleMiddle AgedAPOL1 protein, humanApolipoprotein L1DNAAPOL1cardiovascular diseasecoronary artery calciumheart failureMulti‐Ethnic Study of Atherosclerosis

Identifiers

PMID29269352
PMCPMC5779033
OpenAlexW2780563321

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.